Elicio Therapeutics, Inc. (ELTX) vs ImageneBio, Inc. (IMA)
Elicio Therapeutics, Inc. and ImageneBio, Inc. are both Biotechnology companies. Elicio Therapeutics, Inc. and ImageneBio, Inc. are of similar size ($53.4M and $52.9M). Elicio Therapeutics, Inc. grew revenue faster over the last twelve months: 921.0% against −68.0%. Across the 14 metrics below, ImageneBio, Inc. leads on 8 and Elicio Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ELTX | IMA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (774.56%) | (41.34%) | (57.72%) |
| Return on assets | (124.36%) | (38.34%) | (49.22%) |
| Return on invested capital | 0.00% | (622.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack